Ensign Peak Advisors »

Regeneron Pharmaceuticals shares owned by Ensign Peak Advisors

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Ensign Peak Advisors from 13F filings

Historical chart of Ensign Peak Advisors investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Ensign Peak Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Ensign Peak Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $45M 43k 1051.24
2024-06-30 $135M 129k 1051.03
2024-03-31 $128M 133k 962.49
2023-09-30 $105M 128k 822.96
2023-06-30 $90M 125k 718.54
2023-03-31 $40M 49k 821.67
2022-12-31 $37M 51k 721.49
2022-09-30 $35M 51k 688.87
2022-06-30 $36M 60k 591.13
2022-03-31 $32M 46k 698.42
2021-12-31 $36M 56k 631.54
2021-09-30 $54M 90k 605.19
2021-06-30 $55M 98k 558.54
2021-03-31 $48M 102k 473.14
2020-12-31 $66M 138k 483.11
2020-09-30 $85M 151k 559.78
2020-06-30 $97M 156k 623.64
2020-03-31 $42M 85k 488.31
2019-12-31 $16M 43k 375.49